Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas

Tumori

Volumn 97, Issue 5, 2011, Pages 639-646

  Kim, Young Jin ^a   Kim, Choong Hyun ^b   Cheong, Jin Hwan ^b   Kim, Jae Min ^b  

^a Dankook University College of Medicine   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

Angiogenesis; Intratumoral hemorrhage; Pituitary adenoma; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CAVERNOUS SINUS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GROWTH HORMONE SECRETING ADENOMA; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROLACTINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; THYROTROPIN SECRETING ADENOMA; TUMOR BLEEDING; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 83055163377     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700517     Document Type: Article

References (40)

1. Wakai S, Yamakawa K, Manaka S, Takakura K: Spontaneous intracranial hemorrhage caused by brain tumors: its incidence and clinical significance. Neurosurgery, 10: 437-444, 1982. (Pubitemid 12156777)
2. Kurihara N. Takahashi S, Higano S, Ikeda H, Mugikura S, Singh LN, Furuta S, Tamura H, Ishibashi T, Maruoka S, Yamada S: Hemorrhage in pituitary adenoma: correlation of MR imaging with operative findings. Eur Radiol, 8: 971-976, 1998. (Pubitemid 128662742)
3. Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A: Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol, 36: 1090-1095, 2005. (Pubitemid 41443260)
4. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo-stellate cells. Proc Natl Acad Sci USA, 86: 7311-7315, 1989. (Pubitemid 19254450)
5. Cheng SY, Nagane M, Huang HS, Cavenee WK: Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA, 94: 12081-12087, 1997.
6. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 13: 9-22, 1999. (Pubitemid 29038270)
7. Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S, Yoshioka H, Yamasaki F, Kanou Y: Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Hiroshima J Med Sci, 53: 23-27, 2004. (Pubitemid 39243852)
8. Connolly DT: Vascular permeability factor a unique regulator of blood vessel function. J Cell Biochem, 47: 219-223, 1991.
9. Fukui S, Otani N, Nawashiro H, Yano A, Nomura N, Tokumaru AM, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K: The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma. J Clin Neurosci, 10: 320-324, 2003. (Pubitemid 36713403)
10. Senger DR, Connolly DT, van de Water L, Feder J, Dvorak HF: Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res, 50: 1774-1778, 1990. (Pubitemid 20098819)
11. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci, 108: 2369-2379, 1995.
12. Esser S, Wolburg K, Wolberg H, Breier G, Kurzchalia T, Risau W: Vascular endothelial growth factor induces endothelial fenetrations in vitro. J Cell Biol, 140: 947-959, 1998. (Pubitemid 28141231)
13. Kim JH, Chung YG, Lee HK, Lee KC, Suh JK: Evaluation of cerebrospinal fluid vascular endothelial growth factor for the brain tumor. J Korean Neurosurg Soc, 33: 121-125, 2003.
14. Ke LD, Shi YX, Yung WK: VEGF121, VEGF165 overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells. Cancer Res, 62: 1854-1861, 2002. (Pubitemid 34408513)
15. Yamada S, Takada K. Angiogenesis in pituitary adenomas: Microsc Res Tech, 60: 236-243, 2003.
16. Jung S, Moon KS, Jung TY, Kim IY, Lee YH, Rhu HH, Sun HS, Jeong YI, Kim KK, Kang SS: Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMPs) in metastatic brain tumorassociated intracerebral hemorrhage. J Neurooncol, 76: 257-263, 2006.
17. Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: amagnetic resonance imaging classification compared with surgical findings. Neurosurgery, 33: 610-618, 1993. (Pubitemid 23292752)
18. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U: Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology, 74: 95-105, 2001. (Pubitemid 32727576)
19. Fukui S, Nawashiro H, Otani N, Ooigawa H, Yano A, Nomura N, Tokumaru AM, Miyazawa T, Ohnuki A, Tauzuki N, Katoh H, Ishihara S, Shima K: Vascular endothelial growth factor expression in pituitary adenomas. Acta Neurochir(suppl), 86: 519-521, 2003.
20. Ferrara N, Gerber HP, LeCourt J: The biology of VEGF and its receptors. Nat Med, 9: 669-676, 2003. (Pubitemid 36749215)
21. Hicklin DJ, Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol, 23: 1011-1127, 2005.
22. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm, 161: 851-858, 1989. (Pubitemid 19162712)
23. Jabbour HN, Boddy SC, Lincoln GA. Pattern and localization of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control. Mol Cell Endocrinol, 134: 91-100, 1997. (Pubitemid 27510875)
24. Lloyd RV, Vidal S, Horvath E, Kovacs K, Scheithauer B. Angiogenesis in normal and neoplastic pituitary tissues. Microsc Res Tech 2003; 60: 244-250. (Pubitemid 36125713)
25. Onofri C, Theodoropoulou M, Losa M, Uhl E, Lange M, Arzt E, Stalla GK, Renner U: Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol, 191: 249-261, 2006. (Pubitemid 44756527)
26. Borg SA, Kerry KE, Royds JA, Battersby RD, Jones TH: Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells. Eur J Endocrinol, 152: 293-300, 2005. (Pubitemid 40309578)
27. Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat, 36: 127-137, 1995.
28. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN: Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor associated cysts. J Neurosurg, 83: 682-689, 1995.
29. Vaquero J, Zurita M, Oya S, Coca S, Salas C: Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor associated cysts. J Neuroncol, 41: 3-7, 1999. (Pubitemid 29161016)
30. Vaquero J, Zurita M, Oya S, Coca S, Morales C, Salas C: Expression of vascular permeability factor in cranipharyngioma. J Neurosurg, 91: 831-834, 1999. (Pubitemid 30053156)
31. Mohanty S, Tandon PN, Banerji AK, Prakash B: Haemorrhage into pituitary adenomas. J Neurol Neurosurg Psychiatry, 40: 987-991, 1977. (Pubitemid 8253474)
32. Wakai S, Fukushima T, Teramoto A, Sano K: Pituitary apoplexy: its incidence and clinical significance. J Neurosurg, 55: 187-193, 1981. (Pubitemid 11034232)
33. Mohr G, Hardy J: Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol, 18: 181-189, 1982. (Pubitemid 12032906)
34. Belaud-Rotureau MA, Parrens M, Dubus P, Garroste JC, de Mascarel A, Merlio JP: Comparative analysis of FISH, RTPCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol, 15(5): 517-525, 2002. (Pubitemid 34521400)
35. Badve S: Equivalency of RT-PCR and immunohistochemistry: fact or factoid. Breast Cancer Res Treat, 116(1):145-147, 2009.
36. Iuchi T, Saeki N, Osato K, Yamaura A: Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas. Acta Neurochir(Wien), 142: 1345-1351, 2000. (Pubitemid 32204507)
37. Kim MS, Jang HD, Kim OL: Surgical results of growth hormone-secreting pituitary adenoma. J Korean Neurosurg Soc. 45(5): 271-274, 2009.
38. Oshino S, Saitoh Y, Kasayama S, Arita N, Ohnishi T, Kohara H, Izumoto S, Ydshimine T: Short-term preoperative octreotide treatment of GH-secreting pituitary adenoma : predictors of tumor shrinkage. Endocr J, 53(1): 125-132, 2006.
39. Pendl G, Schrottner O, Eustacchio S, Ganz JC, Feichinger K: Cavernous Sinus Meningiomas. What is the strategy: Upfront or adjuvant Gamma knife surgery. Stereotact Funct Neurosurg, 70: 33-40, 1998.
40. Fukui S, Otani N, Nawashiro H, Yano A, Nomura N, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K: Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas. Brain Tumor Pathol, 19(1): 23-29, 2002.